Cantor Fitzgerald Slashes PT on Oncothyreon (ONTY) from $11 to $4
Tweet Send to a Friend
Cantor Fitzgerald today maintained a Buy rating on Oncothyreon (NASDAQ: ONTY) and cut its price target to $4.00 (from $11.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
